Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
Details for Australian Patent Application No. 2003290577 (hide)
International Classifications
Event Publications
8 April 2004 Complete Application Filed
Priority application(s): 60/501,232 19.06.03 US; 60/424,483 07.11.02 US
8 July 2004 Application Open to Public Inspection
Published as AU-B-2003290577
11 December 2008 Application Accepted
Published as AU-B-2003290577
9 April 2009 Standard Patent Sealed
21 January 2010 Amendment Made
The nature of the amendment is: Amend patentee name from Merck & Co., Inc. to Merck Sharp & Dohme Corp.
11 October 2012 Alteration of Name
The name of the patentee has been altered to Merck Sharp & Dohme Corp.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2003290578-TRIPLE-EXPANDED MECHANICAL PIPE COUPLING DERIVED FROM A STANDARD FITTING
2003290576-PREPARATION OF PERFLUORINATED VINYL ETHERS HAVING A SULFONYL FLUORIDE END-GROUP
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser